Novartis Egypt hosted a media workshop in October 2026 to address the critical need for early breast cancer detection and consistent treatment adherence in Egypt.
- Breast cancer accounts for 37.3% of cancer diagnoses among Egyptian women, with 26,052 new cases reported in 2024.
- Data indicates 56% of patients in Egypt are diagnosed at Stage III or IV, complicating treatment and increasing financial burdens.
- Studies show late-stage treatment costs significantly more than early-stage care, impacting both patients and health systems.
- The government’s Presidential Women’s Health Initiative has facilitated over 71.36 million screening and awareness visits since 2019.
Experts and advocates stressed that media engagement remains essential for dispelling misconceptions and promoting timely medical intervention. #BreastCancerAwareness #EgyptHealth #NovartisEgypt @Novartis